Possibly re Swisse.
BKL would be a sell if I had any interest in it (I don't).
A2M and AHF r enuff milk exposure 4 me, one conventional (CDC synergies, P.R.C. growth strategy, marketing), one scientific (A2 protein, NZ company, niche market, marketing to daigou, potential for P.R.C. growth). BKL does not fit my investment profile.
Possibly re Swisse. BKL would be a sell if I had any interest in...
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.90 |
Change
-0.090(1.50%) |
Mkt cap ! $4.271B | |||
| Open | High | Low | Value | Volume |
| $5.96 | $5.97 | $5.86 | $19.03M | 3.213M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4800 | $5.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.91 | 29913 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| A2M (ASX) Chart |